Skip to main content
Clinical Trials/NL-OMON30486
NL-OMON30486RecruitingNot Applicable

Comparison between beta-adrenergic blockers and angiotensin II receptor antagonists for the treatment of late hypertension in patients with repaired aortic coarctation - Treatment of late hypertension in aortic coarctation

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites20 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Diagnosis of aortic coarctation (EPCC code 09.29.01)
  • - Previous repair of aortic coarctation
  • - Age 18-80 years
  • - Current use of anti-hypertensive medication (<3 different drugs), or untreated hypertension, defined as systolic >=140 mmHg or diastolic >=90 mmHg

Exclusion Criteria

  • - Known oversensitivity for candesartan or metoprolol
  • - Severe liver insufficiency (ASAT or ALAT >3ULN)
  • - Current use of >=3 anti-hypertensive drugs
  • - Pregnancy or wish to become pregnant
  • - General contraindications for use of candesartan
  • - General contraindications for use of metoprolol (i.e. bradycardia, sick sinus syndrome etc)

Investigators

Similar Trials

Active, not recruiting
Not Applicable
Comparison between beta-adrenergic blockers and angiotensin II receptor antagonists for the treatment of late hypertension in patients with repaired aortic coarctation - Treatment of late hypertension in aortic coarctatio
EUCTR2006-006861-18-NLDepartment of Cardiology20
Completed
Not Applicable
Comparison of the effects of two beta blockers, bisoprolol and carvedilol on chronic heart failure Bisoprolol Improvement Group for Chronic Heart Failure Treatment Study in Dokkyo Medical University:BRIGHT-DChronic Heart Failure
JPRN-UMIN000011261Dokkyo Medical University Department of Cardiovascular Medicine75
Active, not recruiting
Not Applicable
The effect of beta-adrenergic receptor blockade on sympathetic activity and coagulation in patients with heart failure (BACH-F study) - BACH-F studyCongestive heart failureMedDRA version: 9.1Level: LLTClassification code 10010684Term: Congestive heart failure
EUCTR2007-001994-27-NLetherlands Heart Foundation80
Not yet recruiting
Not Applicable
The effect of beta-adrenergic receptor blockade on sympathetic activity and coagulation in patients with heart failure (BACH-F study)Congestive heart failuresystolic heart failure10019280
NL-OMON31270Academisch Medisch Centrum80
Completed
Not Applicable
The effect of Beta-Adrenergic receptor blockade on sympathetic activity and Coagulation in patients with Heart failure (BACH-F study).1. Heart failure<br />2. Hemostasis<br />3. Sympathetic activity.
NL-OMON21698P.W. Kamphuisen, internist, Vasculair Geneeskundige.80
Comparison between beta-adrenergic... | Clinical Trial